Foresight Autonomous Holdings Ltd. — FY2023 Form 20-F
Reporting period: Fiscal year ended December 31, 2023. This is an annual report, not a standalone 2023 fourth-quarter filing. Financial amounts below are in U.S. dollars unless noted. The company develops 3D vision software and systems for automotive, defense and industrial uses, and cellular-based road-safety applications through Eye-Net Mobile. Its ADSs trade on Nasdaq as FRSX; each ADS represented 30 ordinary shares at year-end.
Financial results and position
| Metric | FY2023 | FY2022 | Change |
|---|---|---|---|
| Revenue | $497,000 | $550,000 | Down 9.6% |
| Gross profit | $354,000 | $298,000 | Up $56,000 |
| Gross margin | 71.2% | 54.2% | Up about 17.0 percentage points |
| Research and development expense, net | $11.587 million | $11.534 million | Up 0.5% |
| Sales and marketing expense | $1.939 million | $2.230 million | Down 13% |
| General and administrative expense | $3.119 million | $3.989 million | Down 22% |
| Operating loss | $16.291 million | $17.455 million | Loss narrowed 7% |
| Net loss | $18.410 million | $21.676 million | Loss narrowed $3.266 million |
| Basic and diluted loss per ordinary share | $0.06 | $0.07 | Loss per share narrowed |
Revenue remained small relative to operating costs. FY2023 revenue included $250,000 from the Elbit commercialization agreement; the filing also identifies paid proof-of-concept and project revenue. One customer accounted for approximately $250,000, or half of annual revenue.
Cash flow: Net cash used in operations was $14.926 million, compared with $17.057 million in 2022. Investing activities provided $7.092 million, principally from the reduction in short-term deposits; financing activities provided $4.181 million, principally from equity issuance. Cash and cash equivalents plus restricted cash fell to $15.734 million from $19.275 million. Capital expenditures were $124,000, versus $313,000.
Liquidity and debt: At December 31, 2023, cash and cash equivalents were $15.635 million, restricted cash $99,000, and current assets $17.047 million. Total liabilities were $3.315 million, including $1.631 million of operating lease liabilities; the balance sheet does not show conventional borrowings. Management said existing cash, cash equivalents and short-term deposits, together with the subsequent Rail Vision sale, were expected to fund current operations through the end of Q2 2025. This is a forecast, not a guarantee.
Material changes versus the prior comparable year
- Revenue declined while gross profit and gross margin improved, reflecting lower cost of revenue.
- Operating and net losses narrowed, largely alongside lower sales and marketing and general and administrative costs; R&D spending was essentially flat.
- Operating cash use improved by $2.131 million, but remained substantial. The reported investing cash inflow mainly reflects deposit movements, not recurring operating cash generation.
- Shares outstanding increased from 322,979,556 to 459,778,056, approximately 42%, principally following the December 2023 registered direct offering. The company issued 4.5 million ADSs for $4.5 million gross proceeds, representing 135 million ordinary shares.
- The company recorded $2.119 million of net financial expense, versus $4.221 million in 2022. FY2023 included a substantial fair-value loss on its Rail Vision investment, partly offset by interest income; lower foreign-exchange losses also helped versus 2022.
Outlook, management commentary and risks
- Management described the company as development-stage, with no significant recurring product revenue and continuing losses. It expects losses to continue until products are successfully commercialized and says additional funding may be needed; financing may dilute shareholders or may not be available on acceptable terms.
- For 2024, management’s stated priorities include expanding paid POCs and co-development work, pursuing SUNWAY airport-ground-vehicle sales, and initiating software-license sales to Elbit’s defense customers. No quantified company-wide revenue or earnings guidance is provided.
- Commercial agreements represent potential, not assured, revenue. The SUNWAY agreement may yield up to $51 million over four years, depending on demand; the Elbit agreement may yield up to $4 million over five years. Conversion to production, customer demand, regulatory clearances and timing remain uncertain.
- At year-end, the company held a 10.2% stake in Rail Vision. It sold the entire investment in February 2024 for approximately $1.848 million net proceeds and reported a $1.407 million finance gain in Q1 2024.
- Eye-Net’s planned integration with Pango was postponed to Q2 2024, and completion remained uncertain as of the report. Eye-Net also reported progress on paid Japanese proof-of-concept work and SoftBank technology validation; these developments do not establish commercial deployment.
- Management said it refocused resources toward defense and industrial vehicles near the end of 2023. Key execution risks include lengthy automotive sales cycles, competition, product development and safety validation, supply-chain dependence, customer cost targets, and the ability to convert trials into recurring sales.
- Israel-based operations face risks from the Israel-Hamas war, possible employee reserve-duty absences, regional instability and uninsured war-related losses. Currency exposure is also material; the company does not hedge foreign-exchange risk.
- IIA-funded technology carries royalty obligations of generally 3%–5% of relevant sales, plus restrictions and possible approval or payment requirements for transferring supported know-how or manufacturing outside Israel. The filing reports approximately $620,000 of grants and contingent obligations as of year-end.
- The company reported no material legal proceedings. It has never paid cash dividends and does not expect to do so in the foreseeable future. Management assessed disclosure controls and internal control over financial reporting as effective at year-end; the auditor did not provide an internal-control attestation because of the company’s emerging-growth-company exemption.
Most important facts for investors to verify
- Whether cash burn, actual post-year-end liquidity and the stated Q2 2025 runway align with management’s forecast, including the effect of the Rail Vision sale and any new financing.
- Whether SUNWAY and Elbit potential contract values produce recognized revenue, and the timing, conditions and customer demand behind any commercial rollout.
- Whether automotive and industrial POCs progress to paid co-development, design wins or recurring software licenses; separately confirm the status of the delayed Pango integration.
- The extent of further equity issuance, use of the January 2024 shelf registration (up to $50 million), and resulting dilution; compare share counts and ADS terms carefully.
- The company’s exposure to Israel-related operational disruption and IIA restrictions or royalties, and whether these affect staffing, commercialization or technology transfers.